The efficacy of robot assisted laparoscopic hysterectomy and pelvic lymphadenectomy.

The efficacy of robot assisted laparoscopic hysterectomy and pelvic lymphadenectomy. - The efficacy of robot assisted laparoscopic hysterectomy and pelvic lymphadenectomy.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007233

Enrollment

Registered

2012-02-07

Start date

2012-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine tumor

Interventions

trial period: 2012/3/1-2013/12/31 method: robot assisted laparoscopic hysterectomy and lymphadenectomy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. benign uterine tumor 2. cervical cancer stage 0-Ia1 3. corpus cancer stage 0-I 4. ECOG-PS 0-1

Exclusion criteria

Exclusion criteria: 1. severe cardio-or cerebro- vascular disease. 2. after radiation therapy in pelvic cavity. 3. severe renal failure. 4. sever liver failure.

Design outcomes

Primary

Measure	Time frame
operation time, complication, recovery period, postoperative pain, histology	—

Countries

Japan

Contacts

Public ContactKunimi, Kotaro

Tokushima university hospital Department of OB/GYN

kunimi@clin.med.tokushima-u.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026